Health Canada issues two recalls for Pfizer blood pressure drugs over impurity
Last year, Pfizer stopped distribution of megablockbuster smoking cessation drug Chantix over an increased level of carcinogenic nitrosamines.
Now, two of the Big Pharma’s blood pressure drugs have been recalled in Canada this week after Canada’s health authority found levels of a type of nitrosamine too high to be allowed in the drugs.
Pfizer Canada recalled all 8 lots of blood pressure drug Accuretic yesterday after higher-than-approved levels of N-nitroso-quinapril were found. That recall was just two days after the pharma subsidiary recalled 15 lots of Inderal-LA, another blood pressure drug, over similar concerns over nitrosamines.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.